Comparative effects of nitrendipine and hydrochlorothiazide on calciotropic hormones and bone density in hypertensive patients

• Published in: American journal of hypertension Vol. 5; no. 12 Pt 1; p. 875
• Main Authors: Giles, T D, Sander, G E, Roffidal, L E, Quiroz, A C, Mazzu, A L
• Format: Journal Article
• Language: English
• Published: United States 01.12.1992
• Subjects: Aged; Aged, 80 and over; Blood Pressure - drug effects; Blood Pressure - physiology; Bone Density - drug effects; Calcitonin - blood; Calcium - blood; Double-Blind Method; Female; Humans; Hydrochlorothiazide - pharmacology; Hypertension - blood; Hypertension - epidemiology; Hypertension - physiopathology; Lumbar Vertebrae - physiology; Male; Middle Aged; Nitrendipine - pharmacology; Parathyroid Hormone - blood; Prospective Studies; Time Factors
• ISSN: 0895-7061
• DOI: 10.1093/ajh/5.12.875

The effects of the calcium antagonist nitrendipine and the diuretic hydrochlorothiazide on plasma calciotropic hormone concentrations and lumbar bone density were compared during the treatment of hypertension in a randomized, double-blind, 8 week parallel study, followed by a 52 week open label study. There were 32 subjects with stable essential hypertension (sitting diastolic blood pressure > or = 95 mm Hg and < or = 115 mm Hg without medication) without evidence of renal insufficiency or active heart disease. They were randomly assigned to receive either 10 mg nitrendipine twice daily or 50 mg hydrochlorothiazide daily. In order to reach and maintain target blood pressure (diastolic blood pressure < or = 95 mm Hg) during the open label period, the nitrendipine dose was titrated up to 30 mg twice daily, and additional antihypertensive drugs, of differing classes, were added as necessary. Blood samples were analyzed for concentrations of calcium, parathyroid hormone, and calcitonin, and lumbar bone density was determined by dual photon absorptiometry, at the baseline and at 24 and 52 weeks of antihypertensive drug therapy.